There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Animalcare (GB:ANCR – Research Report), Ansell (ANSLF – Research Report) and Legend Biotech (LEGN – Research Report) with bullish sentiments.
Animalcare (GB:ANCR)
Stifel Nicolaus analyst Max Herrmann maintained a Buy rating on Animalcare yesterday. The company’s shares closed yesterday at p210.00, equals to its 52-week high of p210.00.
Herrmann has an average return of
According to TipRanks.com, Herrmann is ranked #4500 out of 8799 analysts.
Animalcare has an analyst consensus of Moderate Buy.
See the top stocks recommended by analysts >>
Ansell (ANSLF)
In a report released yesterday, Macquarie from Macquarie upgraded Ansell to Buy, with a price target of A$28.15. The company’s shares closed last Thursday at $15.05.
Currently, the analyst consensus on Ansell is a Hold with an average price target of $17.91, a 19.0% upside from current levels. In a report issued on April 8, Jefferies also upgraded the stock to Buy with a A$30.85 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
